The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Open accessAbstract
Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly progressive interstitial lung disease. Subsequently, the complete clinical spectrum of the disease was enriched by skin, articular and vascular manifestations. Depending on the predominance of these symptoms, three distinct clinical phenotypes with different prognosis are now defined. To date, the only known molecular component shared by the three entities are specific antibodies targeting MDA5, a cytosolic protein essential for antiviral host immune responses. Several biological tools have emerged to detect these antibodies, with drawbacks and limitations for each of them. However, the identification of this highly specific serological marker of the disease raises the question of its role in the pathogenesis. Although current knowledge on the pathogenic mechanisms that take place in the disease are still in their enfancy, several lines of evidence support a central role of interferon-mediated vasculopathy in the development of skin and lung lesions, as well as a possible pathogenic involvement of anti-MDA5 antibodies. Here, we review the clinical and biological evidences in favor of these hypothesis, and we discuss the contribution of emerging therapies that shed some light on the pathogenesis of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888 · cited 2×
“More specifically, MDA5 senses preferentially long (> 300 bp) RNA-RNA strand pairs, which are mainly RNA viruses replicative intermediates, although some DNA viruses also produce them during their life cycle (71, 72).”
BackgroundImpaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science · doi:10.1126/science.abd4585 · Cited by 2,662
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science · doi:10.1126/science.abd4570 · Cited by 2,229
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875 · cited 1×
“Phosphorylated IRF3, IRF7 and NF-kB then accumulate in the nuclei where they activate antiviral gene transcription, including IFN-I genes, leading to the production of type I IFN (IFNa and IFNb) and pro-inflammatory cytokines (73, 74).”
BackgroundRIG-I-like receptors: their regulation and roles in RNA sensing
Rehwinkel, J., & Gack, M. U. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0288-3 · Cited by 1,699
Kato, H., Takeuchi, O., Mikamo-Satoh, E., Hirai, R., Kawai, T., Matsushita, K., Hiiragi, A., Dermody, T. S., Fujita, T., & Akira, S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080091 · Cited by 1,599
Goshua, G., Pine, A. B., Meizlish, M. L., Chang, C.-H., Zhang, H., Bahel, P., Baluha, A., Bar, N., Bona, R. D., Burns, A. J., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30216-7 · Cited by 1,110
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Lee, J. S., Park, S., Jeong, H. W., Ahn, J. Y., Choi, S. J., Lee, H., Choi, B., Nam, S. K., Sa, M., Kwon, J.-S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd1554 · Cited by 825
Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21023 · Cited by 747
Kang, D.-C., Gopalkrishnan, R. V., Wu, Q., Jankowsky, E., Pyle, A. M., & Fisher, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022637199 · Cited by 651
Mitochondrial double-stranded RNA triggers antiviral signalling in humans
Dhir, A., Dhir, S., Borowski, L. S., Jimenez, L., Teitell, M., Rötig, A., Crow, Y. J., Rice, G. I., Duffy, D., Tamby, C., et al. (2018) · Nature · doi:10.1038/s41586-018-0363-0 · Cited by 631
Sato, S., Hoshino, K., Satoh, T., Fujita, T., Kawakami, Y., Fujita, T., & Kuwana, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24621 · Cited by 604
Fiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.016 · Cited by 554
Hanley, B., Naresh, K. N., Roufosse, C., Nicholson, A. G., Weir, J., Cooke, G. S., Thursz, M., Manousou, P., Corbett, R., Goldin, R., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30115-4 · Cited by 535
Mariampillai, K., Granger, B., Amelin, D., Guiguet, M., Hachulla, E., Maurier, F., Meyer, A., Tohmé, A., Charuel, J.-L., Musset, L., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2598 · Cited by 455
Evans, P. C., Rainger, G. E., Mason, J. C., Guzik, T. J., Osto, E., Stamataki, Z., Neil, D., Hoefer, I. E., Fragiadaki, M., Waltenberger, J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa230 · Cited by 437
The type I interferon response in COVID-19: implications for treatment
Lee, J. S., & Shin, E.-C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00429-3 · Cited by 421
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Yin, X., Riva, L., Pu, Y., Martin-Sancho, L., Kanamune, J., Yamamoto, Y., Sakai, K., Gotoh, S., Miorin, L., De Jesus, P. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108628 · Cited by 383
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Zhang, L., Wang, Y., Wu, G., Xiong, W., Gu, W., & Wang, C.-Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0864-2 · Cited by 375
Tsuji, H., Nakashima, R., Hosono, Y., Imura, Y., Yagita, M., Yoshifuji, H., Hirata, S., Nojima, T., Sugiyama, E., Hatta, K., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41105 · Cited by 357
WDFY4 is required for cross-presentation in response to viral and tumor antigens
Theisen, D. J., Davidson, J. T., Briseño, C. G., Gargaro, M., Lauron, E. J., Wang, Q., Desai, P., Durai, V., Bagadia, P., Brickner, J. R., et al. (2018) · Science · doi:10.1126/science.aat5030 · Cited by 346
Siddiqi, H. K., Libby, P., & Ridker, P. M. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.10.005 · Cited by 340
Gono, T., Sato, S., Kawaguchi, Y., Kuwana, M., Hanaoka, M., Katsumata, Y., Takagi, K., Baba, S., Okamoto, Y., Ota, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes102 · Cited by 339
Nakashima, R., Imura, Y., Kobayashi, S., Yukawa, N., Yoshifuji, H., Nojima, T., Kawabata, D., Ohmura, K., Usui, T., Fujii, T., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep375 · Cited by 334
Hamaguchi, Y., Kuwana, M., Hoshino, K., Hasegawa, M., Kaji, K., Matsushita, T., Komura, K., Nakamura, M., Kodera, M., Suga, N., et al. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.52 · Cited by 333
Gono, T., Kawaguchi, Y., Satoh, T., Kuwana, M., Katsumata, Y., Takagi, K., Masuda, I., Tochimoto, A., Baba, S., Okamoto, Y., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq149 · Cited by 319
Hall, J. C., Casciola‐Rosen, L., Samedy, L., Werner, J., Owoyemi, K., Danoff, S. K., & Christopher‐Stine, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21992 · Cited by 307
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications
Nägele, M. P., Haubner, B., Tanner, F. C., Ruschitzka, F., & Flammer, A. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.10.014 · Cited by 300
Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21985 · Cited by 288
Lega, J.-C., Fabien, N., Reynaud, Q., Durieu, I., Durupt, S., Dutertre, M., Cordier, J.-F., & Cottin, V. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.03.004 · Cited by 286
Self-citationType I IFN immunoprofiling in COVID-19 patients
Trouillet-Assant, S., Viel, S., Gaymard, A., Pons, S., Richard, J.-C., Perret, M., Villard, M., Brengel-Pesce, K., Lina, B., Mezidi, M., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.029 · Cited by 265
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells
Feng, Q., Hato, S. V., Langereis, M. A., Zoll, J., Virgen-Slane, R., Peisley, A., Hur, S., Semler, B. L., van Rij, R. P., & van Kuppeveld, F. J. M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.005 · Cited by 252
Wenzel, J., Wörenkämper, E., Freutel, S., Henze, S., Haller, O., Bieber, T., & Tüting, T. (2005) · The Journal of Pathology · doi:10.1002/path.1721 · Cited by 247
Vlahakos, D., Foster, M. H., Ucci, A. A., Barrett, K. J., Datta, S. K., & Madaio, M. P. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v281345 · Cited by 241
Rebendenne, A., Chaves Valadão, A. L., Tauziet, M., Maarifi, G., Bonaventure, B., McKellar, J., Planès, R., Nisole, S., Arnaud-Arnould, M., Moncorgé, O., et al. (2021) · Journal of Virology · doi:10.1128/jvi.02415-20 · Cited by 229
Immunology of IgG4-related disease
Della-Torre, E., Lanzillotta, M., & Doglioni, C. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12641 · Cited by 226
Habib, T., Senadheera, S., Weinberg, K., & Kaushansky, K. (2002) · Biochemistry · doi:10.1021/bi0202023 · Cited by 211
Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
Fillatre, P., Decaux, O., Jouneau, S., Revest, M., Gacouin, A., Robert-Gangneux, F., Fresnel, A., Guiguen, C., Le Tulzo, Y., Jégo, P., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.010 · Cited by 210
Biology of IL‐21 and the IL‐21 receptor
Mehta, D. S., Wurster, A. L., & Grusby, M. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00201.x · Cited by 201
Tansley, S. L., Betteridge, Z. E., Gunawardena, H., Jacques, T. S., Owens, C. M., Pilkington, C., Arnold, K., Yasin, S., Moraitis, E., Wedderburn, L. R., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4600 · Cited by 194
Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
Labrador-Horrillo, M., Martinez, M. A., Selva-O'Callaghan, A., Trallero-Araguas, E., Balada, E., Vilardell-Tarres, M., & Juárez, C. (2014) · Journal of Immunology Research · doi:10.1155/2014/290797 · Cited by 188
Cao, H., Pan, M., Kang, Y., Xia, Q., Li, X., Zhao, X., Shi, R., Lou, J., Zhou, M., Kuwana, M., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21728 · Cited by 187
Romero-Bueno, F., Diaz del Campo, P., Trallero-Araguás, E., Ruiz-Rodríguez, J. C., Castellvi, I., Rodriguez-Nieto, M. J., Martínez-Becerra, M. J., Sanchez-Pernaute, O., Pinal-Fernandez, I., Solanich, X., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.03.007 · Cited by 184
Damoiseaux, J. G. M. C., Vulsteke, J., Tseng, C., Platteel, A. C. M., Piette, Y., Shovman, O., Bonroy, C., Hamann, D., Langhe, E. D., Musset, L., et al. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.10.004 · Cited by 176
Advances in serological diagnostics of inflammatory myopathies
Benvéniste, O., Stenzel, W., & Allenbach, Y. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000376 · Cited by 174
How does endothelial cell injury start? The role of endothelin in systemic sclerosis
Abraham, D., & Distler, O. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2186 · Cited by 166
Identification of Genes Selectively Regulated by IFNs in Endothelial Cells
Indraccolo, S., Pfeffer, U., Minuzzo, S., Esposito, G., Roni, V., Mandruzzato, S., Ferrari, N., Anfosso, L., Dell’Eva, R., Noonan, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1122 · Cited by 158
Kobayashi, N., Takezaki, S., Kobayashi, I., Iwata, N., Mori, M., Nagai, K., Nakano, N., Miyoshi, M., Kinjo, N., Murata, T., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/keu385 · Cited by 153
Tansley, S., Li, D., Betteridge, Z., & McHugh, N. J. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa021 · Cited by 148
Moghadam‐Kia, S., Oddis, C. V., Sato, S., Kuwana, M., & Aggarwal, R. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.160682 · Cited by 139
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody
Tanizawa, K., Handa, T., Nakashima, R., Kubo, T., Hosono, Y., Watanabe, K., Aihara, K., Oga, T., Chin, K., Nagai, S., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.05.006 · Cited by 138
Gonçalves, D., Mezidi, M., Bastard, P., Perret, M., Saker, K., Fabien, N., Pescarmona, R., Lombard, C., Walzer, T., Casanova, J., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1327 · Cited by 133
Self-citationType I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis
Wenzel, J., Schmidt, R., Proelss, J., Zahn, S., Bieber, T. R. M., & Tüting, T. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02150.x · Cited by 129
Deakin, C. T., Yasin, S. A., Simou, S., Arnold, K., Tansley, S., Betteridge, Z., McHugh, N. J., Varsani, H., Holton, J. L., Jacques, T. S., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39753 · Cited by 114
Wendel, S., Venhoff, N., Frye, B. C., May, A. M., Agarwal, P., Rizzi, M., Voll, R. E., & Thiel, J. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.03.003 · Cited by 108
Motegi, S., Sekiguchi, A., Toki, S., Kishi, C., Endo, Y., Yasuda, M., Ikeuchi, H., Sakairi, T., Hara, K., Yamaguchi, K., et al. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3634 · Cited by 103
Ishida, Y., Kimura, A., Nosaka, M., Kuninaka, Y., Hemmi, H., Sasaki, I., Kaisho, T., Mukaida, N., & Kondo, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-17007-8 · Cited by 102
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies
Allenbach, Y., Leroux, G., Suárez‐Calvet, X., Preuße, C., Gallardo, E., Hervier, B., Rigolet, A., Hie, M., Pehl, D., Limal, N., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.010 · Cited by 101
Kobayashi, I., Okura, Y., Yamada, M., Kawamura, N., Kuwana, M., & Ariga, T. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.033 · Cited by 98
Huang, K., Vinik, O., Shojania, K., Yeung, J., Shupak, R., Nimmo, M., & Aviña-Zubieta, J. A. (2019) · Rheumatology International · doi:10.1007/s00296-019-04398-2 · Cited by 94
Zhang, S. H., Zhao, Y., Xie, Q., Jiang, Y., Wu, Y., & Yan, B. (2018) · British Journal of Dermatology · doi:10.1111/bjd.16917 · Cited by 92
The Splicing Factor Proline-Glutamine Rich (SFPQ/PSF) Is Involved in Influenza Virus Transcription
Landeras-Bueno, S., Jorba, N., Pérez-Cidoncha, M., & Ortı́n, J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002397 · Cited by 91
Horai, Y., Koga, T., Fujikawa, K., Takatani, A., Nishino, A., Nakashima, Y., Suzuki, T., Kawashiri, S., Iwamoto, N., Ichinose, K., et al. (2014) · Modern Rheumatology · doi:10.3109/14397595.2014.900843 · Cited by 88
Li, Y., Gao, X., Li, Y., Jia, X., Zhang, X., Xu, Y., Gan, Y., Li, S., Chen, R., He, J., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00363 · Cited by 87
Muro, Y., Sugiura, K., Hoshino, K., Akiyama, M., & Tamakoshi, K. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3547 · Cited by 86
Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies
Mähler, M., Betteridge, Z., Bentow, C., Richards, M., Seaman, A., Chinoy, H., & McHugh, N. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00848 · Cited by 86
Ono, N., Kai, K., Maruyama, A., Sakai, M., Sadanaga, Y., Koarada, S., Inoue, T. K., & Tada, Y. (2018) · Lara D. Veeken · doi:10.1093/rheumatology/key386 · Cited by 83
Horiike, Y., Suzuki, Y., Fujisawa, T., Yasui, H., Karayama, M., Hozumi, H., Furuhashi, K., Enomoto, N., Nakamura, Y., Inui, N., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez185 · Cited by 83
Kochi, Y., Kamatani, Y., Kondo, Y., Suzuki, A., Kawakami, E., Hiwa, R., Momozawa, Y., Fujimoto, M., Jinnin, M., Tanaka, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212149 · Cited by 81
IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells
Brodeur, T. Y., Robidoux, T. E., Weinstein, J. S., Craft, J. E., Swain, S. L., & Marshak‐Rothstein, A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500777 · Cited by 79
Neutrophils Express Distinct RNA Receptors in a Non-canonical Way
Berger, M., Hsieh, C.-Y., Bakele, M., Marcos, V., Rieber, N. P., Kormann, M., Mays, L., Hofer, L., Neth, O., Vitkov, L., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353557 · Cited by 72
Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus
Wenzel, J., Zahn, S., Bieber, T. R. M., & Tüting, T. (2008) · Archives of Dermatological Research · doi:10.1007/s00403-008-0892-8 · Cited by 69
Nakano, M., Fujii, T., Hashimoto, M., Yukawa, N., Yoshifuji, H., Ohmura, K., Nakaizumi, A., & Mimori, T. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04638.x · Cited by 68
Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?
Giannini, M., Ohana, M., Nespola, B., Zanframundo, G., Gény, B., & Meyer, A. (2020) · European Respiratory Journal · doi:10.1183/13993003.01618-2020 · Cited by 66
Takada, T., Aoki, A., Asakawa, K., Sakagami, T., Moriyama, H., Narita, I., & Sato, S. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.07.004 · Cited by 65
Mamyrova, G., Kishi, T., Shi, M., Targoff, I. N., Huber, A. M., Curiel, R., Miller, F. W., Rider, L. G., & for the Childhood Myositis Heterogeneity Collaborative Study Group (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa429 · Cited by 55
Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report
Quintana-Ortega, C., Remesal, A., de Valbuena, M. R., de la Serna, O., Laplaza-González, M., Álvarez-Rojas, E., Udaondo, C., Alcobendas, R., & Murías, S. (2020) · Modern Rheumatology Case Reports · doi:10.1080/24725625.2020.1832755 · Cited by 52
In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies
Deng, S. X., Hanson, E. M., & Sanz, I. (2000) · International Immunology · doi:10.1093/intimm/12.4.415 · Cited by 50
Huang, W., Ren, F., Luo, L., Zhou, J. M., Huang, D., Pan, Z., & Tang, L. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa266 · Cited by 50
Gono, T., Miyake, K., Kawaguchi, Y., Kaneko, H., Shinozaki, M., & Yamanaka, H. (2012) · Lara D. Veeken · doi:10.1093/rheumatology/kes012 · Cited by 49
Greco-Stewart, V. S., Thibault, C. S., & Pelchat, M. (2006) · Virology · doi:10.1016/j.virol.2006.06.040 · Cited by 45
Peng, Q., Zhang, Y.-M., Liang, L., Liu, X., Ye, L.-F., Yang, H.-B., Zhang, L., Shu, X.-M., Lu, X., & Wang, G.-C. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13404 · Cited by 45
Fujisawa, T., Hozumi, H., Yasui, H., Suzuki, Y., Karayama, M., Furuhashi, K., Enomoto, N., Nakamura, Y., Inui, N., & Suda, T. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180825 · Cited by 41
Antibodies to an Intracellular Antigen Penetrate Neuronal Cells and Cause Deleterious Effects
Douglas, J. N. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000134 · Cited by 40
CXCR3 <-> ligand–mediated skin inflammation in cutaneous lichenoid graft-versus-host disease
Wenzel, J., Lucas, S., Zahn, S., Mikus, S., Metze, D., Ständer, S., von Stebut, E., Hillen, U., Bieber, T. R. M., & Tüting, T. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.10.647 · Cited by 36
Nagashima, T., Kamata, Y., Iwamoto, M., Okazaki, H., Fukushima, N., & Minota, S. (2019) · Rheumatology International · doi:10.1007/s00296-019-04255-2 · Cited by 36
Mao, M., Xia, S., Guo, B., Qian, W.-P., Zheng, Z.-X., Peng, X., Chen, R., Luo, Q., & Han, Q. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.105983 · Cited by 33
Mitochondrial dsRNA: A New DAMP for MDA5
Linder, A., & Hornung, V. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.08.019 · Cited by 22
Hosono, Y., Nakashima, R., Serada, S., Murakami, K., Imura, Y., Yoshifuji, H., Ohmura, K., Naka, T., & Mimori, T. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.11.006 · Cited by 19
A rare form of dermatomyositis associated with muscle weakness and normal creatine kinase level
Kwan, C., Milosevic, S., Benham, H., & Scott, I. A. (2020) · BMJ Case Reports · doi:10.1136/bcr-2019-232260 · Cited by 12
Liu, C., Wang, Q., Wang, Y., Geng, W., Wang, L., Chen, H., Jiao, T., Hu, C., Lei, X., Guo, L., et al. (2020) · medRxiv · doi:10.1101/2020.07.29.20164780 · Cited by 12
Scirocco, C., Gubbiotti, A., Sebastiani, A., & Sebastiani, G. D. (2020) · Case Reports in Rheumatology · doi:10.1155/2020/8145790 · Cited by 3
Metadata
- Authors
- Nombel, A., Fabien, N., & Coutant, F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-10-20
- Volume
- 12
- Pages
- 773352-773352
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3209491026
- Cited by
- 262
- References
- 96
- FWCI
- 26.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.